Form D · Pharmaceuticals
NEURALTUS PHARMACEUTICALS, INC.
San Bruno, CA · CIK 0001459308
Offering snapshot reported May 24, 2016 · SEC filing
- Reported sold
- $14.9M Offering amount: $21.9M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 17, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2016 | Initial | $14,938,357 | No comparison | 4 | SEC filing |
| May 31, 2012 | Amendment | $11,125,649 | $1,500,218vs Dec 20, 2011 | 22 | SEC filing |
| Dec 20, 2011 | Initial | $9,625,431 | No comparison | 7 | SEC filing |
| Apr 7, 2009 | Initial | $4,893,853 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-263767
Source: Form D, filed May 24, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ari Azhir | Director, Executive |
| Annette Bianchi | Director |
| Richard Casey | Director, Executive |
| Andrew Gengos | Director, Executive |
| Terry Gould | Director |
| Donald Mc Govern | Director |
| John Walker | Director |
| John Whelan | Executive |
| James Woody | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1001 Bayhill Drive Suite 300
San Bruno, CA, 94066
San Bruno, CA, 94066